Cancer-Cell-Activated Photodynamic Therapy Assisted by Cu(II)-Based Metal–Organic Framework

• Published in: ACS nano Vol. 13; no. 6; pp. 6879 - 6890
• Main Authors: Wang, Yuanbo, Wu, Wenbo, Liu, Jingjing, Manghnani, Purnima Naresh, Hu, Fang, Ma, Dou, Teh, Cathleen, Wang, Bo, Liu, Bin
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 25.06.2019
• Subjects: aggregation-induced emission; photosensitizers; activatable photodynamic therapy; metal−organic frameworks; glutathione
• ISSN: 1936-0851; 1936-086X; 1936-086X
• DOI: 10.1021/acsnano.9b01665

Activation of photosensitizers (PSs) in targeted lesion and minimization of reactive oxygen species (ROS) depletion by endogenous antioxidants constitute promising approaches to perform highly effective image-guided photodynamic therapy (PDT) with minimal non-specific phototoxicity. Traditional strategies to fabricate controllable PS platforms rely on molecular design, which requires specific modification of each PS before PDT. Therefore, construction of a general tumor-responsive PDT platform with minimum ROS loss from endogenous antioxidant, typically glutathione (GSH), is highly desirable. Herein, MOF-199, a Cu­(II) carboxylate-based metal–organic framework (MOF), is selected to serve as an inert carrier to load PSs with prohibited photosensitization during delivery. After cellular uptake, Cu (II) in the MOFs effectively scavenges endogenous GSH, concomitantly induces decomposition of MOF-199 to release the encapsulated PSs, and recovers their ROS generation. In vitro and in vivo experiments demonstrate highly effective cancer cell ablation and anticancer PDT with diminished normal cell phototoxicity. This strategy is generally applicable to PSs with both aggregation-induced emission and aggregation-caused quenching to implement activatable and enhanced image-guided PDT.